Primary healthcare-friendly prostate cancer prediction model using routine clinical parameters: a multicenter study

Read full text Summarise with VIRAT
Authors: Minglong Chen, Tingting Li, ShuPing Yang, You Zhou, Hanzong Lin, Jinxin Lan, Xiaoqian Zhang, Xiao Yang, Jiguang Zhou, Guorong Lyu
Cited by: 0
References: 41

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Objective This study aimed to develop and validate a nomogram model integrating routinely available parameters, making it applicable to primary healthcare settings for optimizing prostate cancer (PCa) risk stratification in patients with elevated prostate-specific antigen (PSA) levels, aiming to reduce unnecessary biopsies. Methods This study included a retrospective cohort of 2, 844 patients who underwent prostate biopsy (885 malignant and 1, 959 benign cases), who were randomly allocated to a training set and an internal validation set in a 7:3 ratio. Independent predictive factors were selected through univariate analyses and multivariate logistic regression analyses, and a nomogram was constructed. The model’s performance was evaluated using Receiver Operating Characteristic (ROC) curve analysis, precision-recall (PR) curves, calibration curve, and decision curve analysis (DCA). Further validation was conducted using an external independent dataset ( n = 281; 93 malignant and 188 benign cases) to assess the model’s generalizability. Results The nomogram model incorporated prostate volume, total PSA (tPSA), free-to-total PSA ratio (f/t PSA), and age, demonstrating discriminative performance with AUC values of 0.816 (95% CI: 0.796–0.836; training set), 0.833 (95% CI: 0.802–0.862; internal validation set), and 0.776 (95% CI: 0.720–0.832; external validation set). Its clinically acceptable performance outperformed that of individual parameters in the training set (all p-values

Fields of Study & Subjects

Prostate Cancer Diagnosis and Treatment Inflammatory Biomarkers in Disease Prognosis Prostate Cancer Treatment and Research

Publication details

Journal / source
Frontiers in Oncology
Volume
16
Pages
1787090–1787090
Publication date
31 March 2026
Language
EN